PO-017 Androgen deprivation and oxidative phosporylation inhibition pose synergistic antitumor effects in subsets of prostate tumours in vitro

Abstract

Introduction Cancer cells are able to survive oxidative phosphorylation (OXPHOS) inhibition by up-regulation of glycolysis. Androgens stimulate glycolysis in prostate cancer cells through activation of the androgen receptor (AR). Here we hypothesise that androgens might help subsets of prostate cancer cells to survive OXPHOS inhibition. In addition, the combined androgen signalling and OXPHOS inhibition might pose synergistic anti-tumour effects in vitro. Material and methods The effects of suppressing OXPHOS with 100 ng/ml oligomycin in charcoal stripped serum media (CSS), before and after the addition of 40 ng/dl testosterone in VCAP, LNCaP, and LNCaP-C4-2B cells in vitro were evaluated. Tumour cell viability after 72 hours was estimated using MTT assay. Results and discussions The addition of 100 ng/ml oligomycin to VCAP cells in a steroid-depleted environment (CSS) dramatically decreased cell viability compared to CSS alone (p Conclusion The combined androgen depletion and OXPHOS inhibition shows promising synergistic anti-tumour effects in vitro.